The Current Ratio as of December 2024 (TTM) for Rocket Pharmaceuticals, Inc. (RCKT) is 6.05

According to Rocket Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.05. This represents a change of -24.66% compared to the average of 8.03 of the last 4 quarters.

Rocket Pharmaceuticals, Inc. (RCKT) Historical Current Ratio (quarterly & annually)

How has RCKT Current Ratio performed in the past?

The mean historical Current Ratio of Rocket Pharmaceuticals, Inc. over the last ten years is 15.09. The current 6.05 Current Ratio has changed 3.91% with respect to the historical average. Over the past ten years (40 quarters), RCKT's Current Ratio was at its highest in in the September 2015 quarter at 36.76. The Current Ratio was at its lowest in in the December 2014 quarter at 0.51.

Rocket Pharmaceuticals, Inc. (RCKT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Rocket Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rocket Pharmaceuticals, Inc. (RCKT) Average Current Ratio

How has RCKT Current Ratio performed in the past?

The current Current Ratio of Rocket Pharmaceuticals, Inc. (RCKT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Rocket Pharmaceuticals, Inc. (RCKT) Current Ratio vs. Peers

How is RCKT’s Current Ratio compared to its peers?

Rocket Pharmaceuticals, Inc.’s Current Ratio is less than uniQure N.V. (6.51), greater than Rhythm Pharmaceuticals, Inc. (3.49), less than Solid Biosciences Inc. (7.85), greater than MeiraGTx Holdings plc (2.34), less than Vaxcyte, Inc. (17.88), less than Larimar Therapeutics, Inc. (13.10), less than Syndax Pharmaceuticals, Inc. (6.99), less than Merus N.V. (8.32), greater than Sutro Biopharma, Inc. (3.09), greater than Stoke Therapeutics, Inc. (5.09), less than Pliant Therapeutics, Inc. (10.26), less than Dyne Therapeutics, Inc. (17.02), less than Cytokinetics, Incorporated (9.28), less than Revolution Medicines, Inc. (14.24), greater than REGENXBIO Inc. (3.05), less than Day One Biopharmaceuticals, Inc. (14.62), less than Replimune Group, Inc. (10.11), greater than Mirum Pharmaceuticals, Inc. (3.34), less than Viridian Therapeutics, Inc. (18.55), less than Inozyme Pharma, Inc. (7.68),

Build a custom stock screener for Rocket Pharmaceuticals, Inc. (RCKT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rocket Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rocket Pharmaceuticals, Inc. (RCKT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rocket Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.